| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,117 | 1,083 | 1,855 | 4,476 | | Cost of Revenue | 2,269 | 990 | 1,368 | 3,113 | | | Gross Profit | 848 | 93 | 487 | 1,363 | | | Operating Expenses | | Research Development | 1,170 | 1,241 | 1,787 | 1,143 | | Selling General and Administrative | 1,483 | 1,864 | 1,811 | 1,636 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,805) | (3,012) | (3,111) | (1,416) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 117 | 354 | (136) | 51 | | Earnings Before Interest And Taxes | (1,688) | (2,658) | (3,247) | (1,365) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,688) | (2,658) | (3,247) | (1,365) | | Income Tax Expense | 1 | (51) |
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,689) | (2,607) | (3,247) | (1,365) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,689) | (2,607) | (3,247) | (1,365) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,689) | ($2,607) | ($3,247) | ($1,365) |
|
0.11% Nasdaq 0.00%
Income Statement
